Navigation Links
Viral protein influences key cell-signaling pathway

New research shows that a protein produced by a cancer-causing virus influences a key signaling pathway in the immune cells that the virus infects. This stimulates the cells to divide, helping the virus spread through the body.

The study, led by researchers at Ohio State University, examined the human T lymphotropic virus type 1 (HTLV-1) and a protein that it produces called p12.

The research is published in the April issue of the journal AIDS Research and Human Retroviruses.

The study found that p12 increases the activity of an important gene in host cells. That gene controls production of a cell protein called p300. The p300 protein, in turn, controls a variety of other genes in many types of cells, including T lymphocytes, the cells that HTLV-1 infects.

The findings might help scientists better understand how HTLV-1 maintains its lifelong infection and how the normal immune cells that "remember" a vaccination or an infection can survive for years or even decades.

"The p300 protein is an important central regulator of gene activity in lymphocytes and many other kinds of cells," says Michael Lairmore, professor and chair of veterinary biosciences and a member of the OSU Comprehensive Cancer Center ?Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. "We were surprised to see p300 show-up among the many genes affected by this viral protein."

HTLV-1 infects an estimated 15 to 20 million people worldwide. In about five percent of them, the infection will lead to adult T cell leukemia or lymphoma (ATLL). ATLL is an aggressive disease characterized by a long latent period and the proliferation of T lymphocytes. The virus is spread by sexual activity, by contact with infected blood and by infected women to children through breast milk.

HTLV-1, like its cousin HIV, inserts its genetic information permanently into the DNA of a T lymphocyte and remains there for the life of the cell. HTLV-1 infecti on is also lifelong. A hallmark of HTLV-1 infection is the proliferation of T lymphocytes.

This sets HTLV-1 apart from HIV, Lairmore says. "Unlike HIV, which kills cells and destroys the immune system, HTLV-1 enhances the survival of T cells."

But scientists don't understand how it prolongs T-cell survival and causes their proliferation.

This study's findings offer some clues. It is the latest in a series of studies led by Lairmore that examine how HTLV-1 affects T lymphocytes and causes cancer.

The p12 gene is called an "accessory gene" because the protein encoded by the gene seemed unnecessary since the virus could still reproduce, or replicate, in cells grown in the laboratory even when p12 was missing.

"But viruses do not keep genes unless they have a purpose," Lairmore says. In an earlier study, Lairmore and his colleagues tried to infect an animal model with an HTLV-1 that lacked the p12 gene, and it stopped the virus from replicating almost entirely.

"That told us this gene was important," he says.

Subsequent research led by Lairmore showed that the p12 protein travels to the network of membranes within the cell known as the rough endoplasmic reticulum (RER). Among other things, the RER helps regulate the amount of calcium in the cell. The investigators found that the p12 protein allows calcium to leak out of the RER, thereby causing calcium levels to rise elsewhere in the cell.

"Calcium is exquisitely regulated in cells," Lairmore says. "When p12 affects that balance, it affects the activity of a variety of genes."

The current study used a non-infectious form of HIV to transplant the HTLV-1 p12 gene into laboratory-grown T cells. The infected cells then produced a constant level of p12 protein. The researchers then used gene microarray technology to identify which cellular genes out of 33,000 become either more or less active due to the p12 protein.

The researchers found that p12 altered the activity of a variety of genes linked to chemical pathways that control cell signaling, proliferation and death. The p300 gene stood out as one showing increased activity. Taken overall, the findings suggest that HTLV-1 p12 protein influences the genetic activity of infected T cells to stimulate their proliferation and promote efficient viral infection.


'"/>

Source:Ohio State University


Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
3. Viral protein helps infected T cells stick to uninfected cells
4. Viral fitness explains different resistance patterns to aids drugs
5. Viral genetic differences are possible key to HIV dementia
6. Viral hitchhiker inhibits Wolbachia bacterias ability to proliferate
7. Viral marker of human migration suspect
8. Viral protein is an effective preventative against infection
9. New, automated tool successfully classifies and relates proteins in unprecedented way
10. New binding target for oncogenic viral protein
11. Controversial drug shown to act on brain protein to cut alcohol use
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... of the QB3@953 life sciences incubator to ... health. The shared laboratory space at QB3@953 was created ... a key obstacle for many early stage organizations - ... of the sponsorship, Amgen launched two "Amgen Golden Ticket" ...
Breaking Biology Technology: